SI7811917A8 - Process for obtaining the crystaline form of the sodium salt of oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid - Google Patents

Process for obtaining the crystaline form of the sodium salt of oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid Download PDF

Info

Publication number
SI7811917A8
SI7811917A8 SI7811917A SI7811917A SI7811917A8 SI 7811917 A8 SI7811917 A8 SI 7811917A8 SI 7811917 A SI7811917 A SI 7811917A SI 7811917 A SI7811917 A SI 7811917A SI 7811917 A8 SI7811917 A8 SI 7811917A8
Authority
SI
Slovenia
Prior art keywords
sodium
ethanol
solvate
sodium salt
water
Prior art date
Application number
SI7811917A
Other languages
English (en)
Slovenian (sl)
Inventor
Gaston Amiard
Dieter Bormann
Walter Duerckheimer
Jean Jolly
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI7811917(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SI7811917A8 publication Critical patent/SI7811917A8/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI7811917A 1977-08-17 1978-08-10 Process for obtaining the crystaline form of the sodium salt of oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid SI7811917A8 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
YU1917/78A YU42166B (en) 1977-08-17 1978-08-10 Process for obtaining the crystalline form of the natrium salt of the oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid

Publications (1)

Publication Number Publication Date
SI7811917A8 true SI7811917A8 (en) 1997-12-31

Family

ID=9194564

Family Applications (1)

Application Number Title Priority Date Filing Date
SI7811917A SI7811917A8 (en) 1977-08-17 1978-08-10 Process for obtaining the crystaline form of the sodium salt of oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid

Country Status (34)

Country Link
US (1) US4224371A (pt)
EP (1) EP0001024B1 (pt)
JP (1) JPS5441890A (pt)
AT (2) AT366049B (pt)
AU (1) AU520898B2 (pt)
BG (2) BG33887A3 (pt)
CA (1) CA1121343A (pt)
CS (2) CS207646B2 (pt)
DD (1) DD137588A5 (pt)
DE (1) DE2860358D1 (pt)
DK (2) DK152213C (pt)
EG (1) EG13520A (pt)
ES (1) ES472381A1 (pt)
FI (1) FI65433C (pt)
FR (1) FR2400519A1 (pt)
GE (2) GEP19960475B (pt)
GR (1) GR73661B (pt)
HR (1) HRP931395B1 (pt)
HU (1) HU181497B (pt)
IE (1) IE47230B1 (pt)
IL (1) IL55186A (pt)
IT (1) IT1107961B (pt)
MD (2) MD225C2 (pt)
MX (2) MX5448E (pt)
NO (1) NO156168C (pt)
NZ (1) NZ188163A (pt)
OA (1) OA06016A (pt)
PL (1) PL126619B1 (pt)
PT (1) PT68431A (pt)
RO (1) RO79999A (pt)
SI (1) SI7811917A8 (pt)
SU (2) SU799666A3 (pt)
YU (1) YU42166B (pt)
ZA (1) ZA784187B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
EP0150507B1 (en) * 1983-12-29 1992-08-05 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives, processes for producing the same and compositions containing them
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPH0749432B2 (ja) * 1985-08-12 1995-05-31 ジ・アップジョン・カンパニ− セファロスポリンハロゲン化水素酸塩のアルカリ金属塩への変換
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (fr) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Procede permettant de remplacer des solvants contenus dans des cristaux de type clathrates
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra

Also Published As

Publication number Publication date
SU799666A3 (ru) 1981-01-23
PL209080A1 (pl) 1979-06-04
ATA52280A (de) 1981-07-15
ZA784187B (en) 1979-09-26
DK159786A (da) 1986-04-09
PT68431A (fr) 1978-09-01
IE47230B1 (en) 1984-01-25
DK163514B (da) 1992-03-09
DK159786D0 (da) 1986-04-09
NZ188163A (en) 1981-10-19
GEP19960476B (en) 1996-07-22
DK361078A (da) 1979-02-18
JPS6145626B2 (pt) 1986-10-08
MX155976A (es) 1988-06-06
NO782782L (no) 1979-02-20
US4224371A (en) 1980-09-23
MD225B1 (ro) 1995-06-30
YU191778A (en) 1983-02-28
FR2400519B1 (pt) 1980-05-16
FR2400519A1 (fr) 1979-03-16
IT7850648A0 (it) 1978-08-08
EG13520A (en) 1982-03-31
SU852175A3 (ru) 1981-07-30
HRP931395B1 (en) 1996-04-30
IT1107961B (it) 1985-12-02
ATA563578A (de) 1981-07-15
FI782494A (fi) 1979-02-18
GEP19960475B (en) 1996-07-22
YU42166B (en) 1988-06-30
DK152213C (da) 1988-07-11
CS207646B2 (en) 1981-08-31
NO156168C (no) 1987-08-19
AU520898B2 (en) 1982-03-04
AT366049B (de) 1982-03-10
FI65433B (fi) 1984-01-31
GR73661B (pt) 1984-03-28
DD137588A5 (de) 1979-09-12
OA06016A (fr) 1981-06-30
DE2860358D1 (en) 1981-03-12
NO156168B (no) 1987-04-27
DK163514C (da) 1992-07-27
BG33887A3 (en) 1983-05-16
HU181497B (en) 1983-07-28
EP0001024B1 (fr) 1981-01-21
FI65433C (fi) 1984-05-10
BG33888A3 (en) 1983-05-16
CS207647B2 (en) 1981-08-31
MD247C2 (ro) 1995-12-31
JPS5441890A (en) 1979-04-03
PL126619B1 (en) 1983-08-31
CA1121343A (fr) 1982-04-06
AU3896578A (en) 1980-02-21
IL55186A (en) 1981-07-31
MD225C2 (ro) 1995-12-31
MD247B1 (ro) 1995-07-31
EP0001024A1 (fr) 1979-03-07
RO79999A (ro) 1982-10-11
DK152213B (da) 1988-02-08
MX5448E (es) 1983-08-09
ES472381A1 (es) 1979-03-16
IL55186A0 (en) 1978-09-29
IE781669L (en) 1979-02-17
AT366050B (de) 1982-03-10

Similar Documents

Publication Publication Date Title
SI7811917A8 (en) Process for obtaining the crystaline form of the sodium salt of oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid
DE2713272C2 (de) Derivate der 7-Aminothiazolyl-acetamido-cephalosporansäure, ihre Herstellung und pharmazeutische Zusammensetzungen
RU2015137928A (ru) Полиморфные и псевдоплиморфные формы фармацевтического соединения
DE2702501C2 (de) Oximderivate von 7-Aminothiazolylacetamidocephalosporansäure (syn-Isomere), ihre Herstellung und pharmazeutische Zusammensetzungen
JPH045038B2 (pt)
JPS6226222A (ja) 細菌性感染症治療剤
EP0004956A1 (de) Beta-Lactamantibiotika, Verfahren zu ihrer Herstellung, Futterzusatzmittel, Arzneimittel sowie Verfahren zu deren Herstellung
DE2812570A1 (de) Oximderivate der 7-aminothiazolyl- acetamido-cephalosporansaeure, ihre herstellung und pharmazeutische zusammensetzungen
DE2217563A1 (de) Verfahren zur Herstellung von Acylaminoverbindungen
CH638221A5 (fr) Oximes derivees de l'acide 3-substitue 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et les compositions pharmaceutiques les renfermant.
DE2700552C2 (de) Derivate der 7-Aminocephalosporansäure, ihre Herstellung und pharmazeutische Mittel
CH639388A5 (fr) Cephalosporines derivees de l'acide 7-/2-(2-amino 4-thiazolyl) 2-(carboxymethoxyimino) acetamido/ 3-substitue cephalosporanique, leurs procedes de preparation et medicaments les renfermant.
DD261163A5 (de) Verfahren zur reinigung von cephalosporin-antibiotika
DE2806226A1 (de) Oximderivate der 3-thiadiazolylthiomethyl-7-aminothiazolyl-acetamido- cephalosporansaeure, ihr herstellungsverfahren sowie pharmazeutische zusammensetzungen
US4318852A (en) Sodium amoxicillin solvate
DD204257A5 (de) Verfahren zur herstellung von cephalosporinen, die in position 3 substituiert sind
KR0137211B1 (ko) 세팔로스포린유도체의 결정성 2염산염 및 그 제조법
JP3755908B2 (ja) セファロスポリン化合物の晶析法
HU176213B (en) Process for preparing a new crystallic modification of the sodium salt of 7beta-cyanacetylamino-3-acetoxymethyl-cef-3-em-4-carboxylic acid
JPS6011714B2 (ja) セフアロスポリン誘導体およびその製造法
CH643267A5 (fr) Oximes de l'acide 7-amino thiazolyl acetamido cephalosporanique, leurs procedes de preparation et les medicaments les renfermant.
EP3868768A1 (en) Pharmaceutical crystal of contezolid acefosamil, preparation method therefor, and uses thereof
IE43666B1 (en) Cephalosporins
DD137588C4 (de) Verfahren zur Herstellung einer Kristailform von 7-Amino-thiazolyl-azetamidozephalosporansäuresalzen
DE2404592A1 (de) Antibakterielle mittel und deren herstellung